January 1, 2017 Issue of JAMA Dermatology

January 2017, Vol 153, No. 1, Pages 3-112

In This Issue of JAMA Dermatology

Highlights

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):3. doi:10.1001/jamadermatol.2016.1650

Viewpoint

The Need for Ergonomics Education in Dermatology and Dermatologic Surgery: Sit Up Straight, Stand Up Tall, and Carry a Sharp Scalpel

Ashish C. Bhatia, MD, FAAD; Shuai Xu, MD, MSc; June K. Robinson, MD

Abstract Full Text

JAMA Dermatol. 2017;153(1):13-14. doi:10.1001/jamadermatol.2016.4069

This Viewpoint explains the importance of ergonomics education in dermatology and dermatologic surgery to prevent muscoloskeletal injuries.

Editorial

Immunoglobulin E Autoantibodies in Bullous Pemphigoid Detected by Immunoglobulin E Enzyme-Linked Immunosorbent Assays

Takashi Hashimoto, MD; Daisuke Tsuruta, MD, PhD; Norito Ishii, MD

Abstract Full Text

JAMA Dermatol. 2017;153(1):15-17. doi:10.1001/jamadermatol.2016.4593

Greater Precision in Melanoma Prevention

Monika Janda, PhD; Peter Soyer, MD, FACD

Abstract Full Text

JAMA Dermatol. 2017;153(1):18-19. doi:10.1001/jamadermatol.2016.3472

Original Investigation

Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study

Caroline G. Watts, MPH; Christine Madronio, MPhil; Rachael L. Morton, MScMed, PhD; et al.

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):23-29. doi:10.1001/jamadermatol.2016.3327

This population-based study examines the association of patient risk factors with the clinical features, previous history, and family history of melanomas.

Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity

Nina van Beek, MD; Nadine Lüttmann, MD; Franziska Huebner, MD; et al.

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):30-38. doi:10.1001/jamadermatol.2016.3357

This case-control cohort study examines the rate and diagnostic significance of anti-BP180鈥搑eactive IgE in patients with bullous pemphigoid and correlates the presence of anti-BP180鈥搑eactive IgE with disease activity and clinical phenotype.

Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clinical Trial

Mari Wataya-Kaneda, MD, PhD; Ayumi Nakamura, BPharm; Mari Tanaka, MD, PhD; et al.

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):39-48. doi:10.1001/jamadermatol.2016.3545

This randomized clinical trial evaluates the efficacy, safety, and optimal concentrations of a topical sirolimus gel vs placebo for facial angiofibromas in children and adults with tuberous sclerosis complex.

Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population

Adewole S. Adamson, MD, MPP; Elizabeth A. Suarez, MPH; April R. Gorman, MS

Abstract Full Text

free access has audio

JAMA Dermatol. 2017;153(1):49-54. doi:10.1001/jamadermatol.2016.3491

This cohort study analyzes factors associated with primary nonadherence to dermatologic medications and examines whether electronic prescribing is associated with rates of primary nonadherence.

Podcast: Method of Prescribing and Primary Nonadherence to Dermatologic Medication (JAMA Dermatology)

Reliability and Photographic Equivalency of the Scar Cosmesis Assessment and Rating (SCAR) Scale, an Outcome Measure for Postoperative Scars

Jonathan Kantor, MD, MSCE, MA

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):55-60. doi:10.1001/jamadermatol.2016.3757

This study assesses the reliability of using photographs in lieu of live patient scar rating assessments and determines the interrater and intrarater reliability of the SCAR scale.

Brief Report

Safety and Efficacy of a Volumizing Hyaluronic Acid Filler for Treatment of HIV-Associated Facial Lipoatrophy

Derek Ho, BS; Jared Jagdeo, MD, MS

Abstract Full Text

JAMA Dermatol. 2017;153(1):61-65. doi:10.1001/jamadermatol.2016.3827

This open-label, phase 1 and 2 study of hyaluronic acid filler evaluates the safety and efficacy of the filler to treat HIV-associated facial lipoatrophy.

Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations

Takuya Takeichi, MD, PhD; Kazumitsu Sugiura, MD, PhD; Toshifumi Nomura, MD, PhD; et al.

Abstract Full Text

JAMA Dermatol. 2017;153(1):66-70. doi:10.1001/jamadermatol.2016.3601

This case series determines how often patients with pityriasis rubra pilaris (PRP) have pathogenic mutations in CARD14 and which clinical subtype of PRP is caused by CARD14 mutations.

Review

The Epidemiology and Clinicopathological Features of Basal Cell Carcinoma in Patients 80 Years and Older: A Systematic Review

Satish F. K. Lubeek, MD; Lieke J. van Vugt, MD; Katja K. H. Aben, PhD; et al.

Abstract Full Text

JAMA Dermatol. 2017;153(1):71-78. doi:10.1001/jamadermatol.2016.3628

This systematic review examines the epidemiology and clinicopathological features of basal cell carcinoma in patients 80 years and older.

JAMA Dermatology Clinicopathological Challenge

Asymptomatic Cobblestoned Plaques on the Soles

Bahram Razani, MD, PhD; Jeffrey North, MD; Rachel Kornik, MD

Abstract Full Text

JAMA Dermatol. 2017;153(1):79-80. doi:10.1001/jamadermatol.2016.3433

A man in his 60s presented with an asymptomatic shiny indurated plaque on the right plantar foot with no report of fevers, chills, weight loss, or night sweats. What is your diagnosis?

Nonhealing Lower Leg Ulcers

Stacy Reichel, DO; Jeffrey Kushner, DO; Ann Ammond LaFond, MD

Abstract Full Text

JAMA Dermatol. 2017;153(1):81-82. doi:10.1001/jamadermatol.2016.3400

A man in his 50s presented with a keratotic plaque with central ulceration that expressed a straw-colored fluid on the left lower leg. What is your diagnosis?

Polycyclic Eruption of the Thighs

Julia Wu, MD; Rebecca Baxt, MD, MBA; Mark Jacobson, MD

Abstract Full Text

JAMA Dermatol. 2017;153(1):83-84. doi:10.1001/jamadermatol.2016.3354

A young woman had a painful erythematous eruption over her thighs that was worse during winter but no other symptoms; she was a nonsmoker, took no medications, and worked at a horse stable and rode for many hours a day. What is your diagnosis?

Research Letter

Estimated Cost of Sunburn-Associated Visits to US Hospital Emergency Departments

Gery P. Guy Jr, PhD, MPH; Zahava Berkowitz, MSPH, MSc; Meg Watson, MPH

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):90-92. doi:10.1001/jamadermatol.2016.4231

This study uses data from the 2013 Nationwide Emergency Department Sample to report on national estimates of sunburn-associated visits to US emergency departments, as well as their costs.

Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma

Duy C. Tran, BS; A. Dimitrios Colevas, MD; Anne Lynn S. Chang, MD

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):92-94. doi:10.1001/jamadermatol.2016.3884

This study discusses 6 consecutive cases of advanced cutaneous squamous cell carcinoma treated with programmed cell death 1 inhibitors.

Characteristics of Medicare Payments to Dermatologists in 2013

Adewole S. Adamson, MD, MPP; Stacie B. Dusetzina, PhD

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):95-97. doi:10.1001/jamadermatol.2016.3948

This study examines noninstitutional claims for office-based services and dermatology procedures delivered to evaluate the characteristics of Medicare payments to dermatologists.

Black and Hispanic Caregivers鈥� Behaviors, Motivations, and Barriers to Sun Protection in Children Aged 4 to 12 Years in Miami, Florida

Vidhi V. Shah, BA; Audrey A. Jacobsen, BA; Stephanie Mlacker, BS; et al.

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):97-99. doi:10.1001/jamadermatol.2016.3505

This study compares black, Hispanic, and white non-Hispanic caregivers鈥� behaviors, motivations, and barriers to sun protection in children aged 4 to 12 years in Miami, Florida.

Dermatologists鈥� Perceptions, Recommendations, and Use of Sunscreen

Aaron S. Farberg, MD; Alex M. Glazer, MD; Adam C. Rigel, MMS, MS; et al.

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):99-101. doi:10.1001/jamadermatol.2016.3698

This survey study examines US dermatologists鈥� perceptions of the safety and efficacy of sunscreen, recommendations to patients regarding its use, and their personal use of sunscreen.

The Role of Bone Scintigraphy in the Diagnosis of Calciphylaxis

Suchismita Paul, MD; Carlos A. Rabito, MD, PhD; Priyanka Vedak, MD; et al.

Abstract Full Text

free access

JAMA Dermatol. 2017;153(1):101-103. doi:10.1001/jamadermatol.2015.4591

This case-control study assesses the use of bone scintigraphy to diagnose calciphylaxis in cases with the disease and in controls with end-stage renal disease without calciphylaxis.

Observation

Efficacy of Topical Sirolimus (Rapamycin) for the Treatment of Microcystic Lymphatic Malformations

Marta Ivars, MD; Pedro Redondo, MD, PhD

Abstract Full Text

JAMA Dermatol. 2017;153(1):103-105. doi:10.1001/jamadermatol.2016.3697

This case report describes the efficacy of topical sirolimus for the treatment of microcystic lymphatic malformations.

Sirolimus-Associated Rapid Progression of Leg Ulcers in a Renal Transplant Recipient

Mariam B. Totonchy, MD; Oscar R. Colegio, MD, PhD; Sean R. Christensen, MD, PhD

Abstract Full Text

JAMA Dermatol. 2017;153(1):105-106. doi:10.1001/jamadermatol.2016.3546

This case report describes rapid progression of leg ulcers associated with sirolimus treatment in a renal transplant recipient.

Response to Interleukin (IL)-17 Inhibition in an Adolescent With Severe Manifestations of IL-36 Receptor Antagonist Deficiency (DITRA)

Kelly M. Cordoro, MD; Derya Ucmak, MD; Maria Hitraya-Low, BS; et al.

Abstract Full Text

JAMA Dermatol. 2017;153(1):106-108. doi:10.1001/jamadermatol.2016.3490

This case report describes the response to interleukin (IL)-17 inhibition in a male adolescent with severe manifestations of IL-36 receptor antagonist deficiency (DITRA).